Are are all toxins created equal?

Is Botox Really a Toxin? Understanding Botulinum Neurotoxin Treatments

One of the most common questions we hear in clinic is: "Is Botox a toxin?"

The short answer is yes—but not in the way many people imagine.

The term "toxin" often sounds alarming, yet Botulinum Neurotoxin Type A has been used safely in medicine for decades and remains one of the most extensively researched treatments in both medical and aesthetic practice.

Let's take a closer look at what Botox actually is, where it came from, and how the different brands of botulinum toxin available in the UK compare.

What Is Botox?

Botulinum Neurotoxin Type A is a purified bacterial protein produced by the bacterium Clostridium botulinum.

Although most people refer to anti-wrinkle injections as "Botox", Botox is actually just a brand name—much like people often refer to all trainers as "Nikes" or all vacuum cleaners as "Hoovers".

The active ingredient in Botox is Botulinum Neurotoxin Type A, and several different brands containing this same active ingredient are available in the UK.

How Was Botox Discovered?

Interestingly, the cosmetic use of botulinum toxin was discovered entirely by accident.

The development of Botulinum Neurotoxin Type A began in the 1970s when ophthalmologist Dr Alan Scott was searching for a non-surgical treatment for patients with strabismus (squint). He wanted to find an injectable substance capable of weakening specific eye muscles without surgery.

This research eventually led to the development of botulinum toxin type A and the first manufacturing methods for a product called Oculinum.

In 1992, Canadian ophthalmologist Jean Carruthers and dermatologist Alastair Carruthers noticed that patients receiving treatment around the eyes experienced a significant reduction in facial wrinkles. This accidental observation ultimately transformed aesthetic medicine and led to the cosmetic applications we know today.

Oculinum was later acquired by Allergan and became the product now recognised worldwide as Botox®.

What Botulinum Toxin Products Are Available in the UK?

There are several licensed formulations of Botulinum Neurotoxin Type A available in the UK.

Although the products differ in formulation, concentration, complexing proteins and accessory ingredients, they all contain the same active neurotoxin: Botulinum Neurotoxin Type A.

Botox® and Vistabel® (OnabotulinumtoxinA)

Botox contains relatively large neurotoxin protein complexes and the highest amount of clostridial proteins among the commonly used toxin brands.

It also contains Human Albumin as a stabilising ingredient.

Duration: Typically up to 3 months.

Dysport®, Azzalure® and Alluzience® (AbobotulinumtoxinA)

These products contain smaller protein complexes, which may allow greater diffusion or "spread" within treated tissues.

Compared with Botox, they contain significantly less clostridial protein.

Alluzience®

Alluzience differs slightly from traditional Dysport formulations because it:

• Is supplied ready to use

• Contains no Human Albumin

• Contains no animal-derived proteins

• Contains no lactose

Some patients report visible results as early as 24 hours after treatment.

Duration: Up to 6 months in some patients.

Bocouture® and Xeomin® (IncobotulinumtoxinA)

Bocouture and Xeomin are often described as "naked toxins" because they contain no complexing proteins.

They contain Human Albumin and sucrose as stabilising agents.

Because of their simplified formulation, they are considered by many practitioners to be among the purest toxin products currently available.

Duration: Typically up to 3 months.

Daxxify® (DaxibotulinumtoxinA)

Daxxify is one of the newest neurotoxins available internationally and received FDA approval in 2022.

What makes Daxxify particularly interesting is its extended duration of action. Clinical studies suggest results may last significantly longer than traditional toxin products.

Daxxify also contains no human- or animal-derived components.

Duration: Up to 9 months in some patients.

What About Korean Toxins Such as Botulax?

Patients often come across lower-cost toxin brands online or through social media.

One example is Botulax, a Korean botulinum toxin product containing Botulinum Neurotoxin Type A, sodium chloride and Human Albumin.

While licensed in some countries, Botulax is not licensed for aesthetic use in the UK.

The Risks of Unlicensed Toxins

Choosing a reputable medical practitioner is crucial because not all products available internationally meet UK regulatory standards.

Potential risks of unlicensed products include:

• Different active ingredients than those advertised

• Incorrect concentrations of active ingredients

• Contamination during manufacturing or distribution

• Lack of quality control and safety monitoring

• Products containing little or no active ingredient, resulting in ineffective treatment

For patient safety, treatments should always be performed using licensed products obtained through legitimate UK pharmaceutical supply chains.

Can Your Body Become Resistant to Botox?

One of the more fascinating areas of toxin science involves something called immunogenicity.

Immunogenicity refers to the ability of a therapeutic protein to trigger an immune response and stimulate the production of anti-drug antibodies.

Over time, these antibodies may reduce the effectiveness of treatment, causing a patient to become what practitioners refer to as a non-responder.

Why Do Complexing Proteins Matter?

Different toxin formulations contain varying amounts of accessory proteins and complexing proteins.

Current scientific theory suggests that formulations containing higher levels of these proteins may have a greater potential to stimulate antibody formation.

This is one reason why the composition of a toxin can be clinically relevant.

• Botox contains relatively high levels of clostridial proteins.

• Dysport contains lower levels.

• Bocouture/Xeomin contain no complexing proteins.

While treatment resistance remains relatively uncommon in aesthetic practice, it is an important consideration for patients receiving repeated treatments over many years.

With So Many Toxins Available, How Do You Choose?

The reality is that your results are usually influenced far more by the skill, knowledge and experience of your injector than by the specific toxin brand used.

Every experienced practitioner develops preferences based on their own clinical experience and the treatment goals of individual patients.

Certain products may be preferable in specific circumstances—for example:

• Patients with lactose sensitivity may wish to avoid products containing lactose.

• Some patients may prioritise faster onset of action.

• Others may prefer products with fewer accessory proteins.

For most people, however, the best approach is to trust your practitioner's clinical judgement.

The Bottom Line

Botulinum Neurotoxin Type A is one of the most studied and widely used treatments in modern medicine and aesthetics.

While "Botox" has become a household name, it is simply one brand among several licensed neurotoxin products available in the UK. Each formulation has unique characteristics, but all work through the same fundamental mechanism.

When considering treatment, the most important factors are:

• Choosing a qualified medical professional

• Ensuring licensed products are used

• Receiving an individualised treatment plan based on your anatomy and goals

Ultimately, successful toxin treatment depends less on the brand in the syringe and more on the expertise of the practitioner holding it.